【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Targeted therapy – Market size and forecast 2018-2023
• Immunotherapy – Market size and forecast 2018-2023
• Chemotherapy – Market size and forecast 2018-2023
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Merck & Co., Inc.
• Sanofi
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global oncology therapeutics market
Exhibit 02: Segments of global oncology therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Type – Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: Targeted therapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Targeted therapy – Year-over-year growth 2019-2023 (%)
Exhibit 21: Targeted therapies in Phase III for colorectal cancer treatment
Exhibit 22: Immunotherapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Immunotherapy – Year-over-year growth 2019-2023 (%)
Exhibit 24: Chemotherapy – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Chemotherapy – Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by type
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Colorectal cancer rate based on gender in US 2015
Exhibit 32: North America – Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in North America
Exhibit 34: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in Europe
Exhibit 37: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 39: Top 3 countries in Asia
Exhibit 40: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 41: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 42: Top 3 countries in ROW
Exhibit 43: Key leading countries
Exhibit 44: Market opportunity
Exhibit 45: Rate of colorectal cancer by age in the US
Exhibit 46: Global geriatric population
Exhibit 47: Combination therapies for colorectal cancer treatment
Exhibit 48: Late-stage combination therapies for treatment of colorectal cancer
Exhibit 49: Estimated patent expiry dates of a few therapeutics used for colorectal cancer treatment
Exhibit 50: Impact of drivers and challenges
Exhibit 51: Some of the kinase inhibitors under development for colorectal cancer treatment
Exhibit 52: Vendor landscape
Exhibit 53: Landscape disruption
Exhibit 54: Vendors covered
Exhibit 55: Vendor classification
Exhibit 56: Market positioning of vendors 0
Exhibit 57: Bristol-Myers Squibb Company – Vendor overview 1
Exhibit 58: Bristol-Myers Squibb Company – Business segments 1
Exhibit 59: Bristol-Myers Squibb Company – Organizational developments 2
Exhibit 60: Bristol-Myers Squibb Company – Geographic focus 3
Exhibit 61: Bristol-Myers Squibb Company – Key offerings 4
Exhibit 62: Bristol-Myers Squibb Company – Key customers 4
Exhibit 63: Eli Lilly and Company – Vendor overview 5
Exhibit 64: Eli Lilly and Company – Business segments 5
Exhibit 65: Eli Lilly and Company – Organizational developments 6
Exhibit 66: Eli Lilly and Company – Geographic focus 7
Exhibit 67: Eli Lilly and Company – Segment focus 7
Exhibit 68: Eli Lilly and Company – Key offerings 7
Exhibit 69: Eli Lilly and Company – Key customers 8
Exhibit 70: F. Hoffmann-La Roche Ltd – Vendor overview 9
Exhibit 71: F. Hoffmann-La Roche Ltd – Business segments 9
Exhibit 72: F. Hoffmann-La Roche Ltd – Organizational developments 0
Exhibit 73: F. Hoffmann-La Roche Ltd – Geographic focus 1
Exhibit 74: F. Hoffmann-La Roche Ltd – Segment focus 1
Exhibit 75: F. Hoffmann-La Roche Ltd – Key offerings 2
Exhibit 76: F. Hoffmann-La Roche Ltd – Key customers 2
Exhibit 77: Merck & Co., Inc. – Vendor overview 3
Exhibit 78: Merck & Co., Inc. – Business segments 3
Exhibit 79: Merck & Co., Inc. – Organizational developments
Exhibit 80: Merck & Co., Inc. – Geographic focus
Exhibit 81: Merck & Co., Inc. – Segment focus
Exhibit 82: Merck & Co., Inc. – Key offerings
Exhibit 83: Merck & Co., Inc. – Key customers
Exhibit 84: Sanofi – Vendor overview
Exhibit 85: Sanofi – Business segments
Exhibit 86: Sanofi – Organizational developments
Exhibit 87: Sanofi – Geographic focus
Exhibit 88: Sanofi – Segment focus
Exhibit 89: Sanofi – Key offerings
Exhibit 90: Sanofi – Key customers
Exhibit 91: Validation techniques employed for market sizing
【レポート販売概要】
■ タイトル：結腸直腸癌治療薬の世界市場2019-2023■ 英文：Global Colorectal Cancer Therapeutics Market 2019-2023
■ 発行日：2019年2月22日
■ 調査会社：Technavio
■ 商品コード：IRTNTR30886
■ 調査対象地域：グローバル、アジア、北米、ヨーロッパ（EMEA）
- アンドロイド端末データベース（Android Devices Database: Activations by Vendor, Handset Model & Region Q4'2011）With global shipments increasing to an all time high of 1.5 Billion units, Android Smartphones have maintained a global Smartphone market share of over 47 %, with 4 major vendors (Samsung, HTC, Motorola Mobility & LG) accounting for 80 % of all Android devices. Google recently announced in its Q4 2011 conference call that the total number of android activations had surpassed 250 million in Q4’2011 …
- レーザー加工の世界市場分析：製品別（ガス、ソリッドステート、ファイバー）、プロセス別（材料加工、マーキング、マイクロ加工）、用途別（自動車、航空宇宙、医療）、セグメント予測、2014-2025The global laser processing market is expected to reach USD 23 billion by 2025, according to a new report by Grand View Research, Inc. The rising utilization of expensive laser-drilling technique for oil & gas exploration purposes is projected to substitute the traditional techniques. Decreasing drilling costs are anticipated to increase the feasibility of uneconomic oil deposits; thus, positively …
- 顔認識システムの世界市場2015-2019About Facial Recognition Facial recognition is a technology used for the identification of individuals. Facial recognition system measures the overall facial feature of a person such as nose, jaw edges, mouth, and the distance between eyes. Facial recognition is used for access control in restricted or high-security areas such as private and public buildings. Facial recognition is largely used in …
- 世界のフレキソ印刷インキ市場2015The Global Flexographic Printing Inks Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Flexographic Printing Inks industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Flexographic Printing Inks market analysis is provided for the international markets …
- 1ブテンの世界市場：需要・供給および価格分析Asia-Pacific dominates the market for 1-butene and China is the biggest producer of 1-butene in the world. 1-butene is mono butene and can be obtained from several sources butnotable are: • Natural gas • Naphtha • Butane • Ethylene etc.
- 世界の保冷市場：ガラス繊維、ポリウレタンフォーム、発泡スチロールなどRising need for energy efficiency, reduction in Green House emissions, sustainable developments and growing infrastructure will drive the global cold insulation market to $4.8billion by 2018. U.S. leads the world in terms of usage of advanced materials to increase the efficiency and reliability of operations that makes it the biggest market. The market here is expected to experience highest revenu …
- クラウド型ビデオサービスの世界市場予測（～2021）MarketsandMarkets forecasts the Video-as-a-Service (VaaS) market size to grow from USD 390.3 Million in 2016 to USD 1,587.4 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 32.4% from 2016 to 2021. The increasing number of connected devices, proliferation of smartphones, rising BYOD trends, increase in the adoption of cloud services by Small and Medium Enterprises (SMEs), lower total co …
- Obesity Therapeutics to 2019 – Safety Concerns Hinder Drug Performance Despite Large Market OpportunityObesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity Summary GBI Research, the leading business intelligence provider, has released its latest research, “Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity”. Obesity is often described as a global endemic, with incidence dramatically increasing ov …
- 鼻炎(Rhinitis)：世界の治験レビュー2014年下半期版Rhinitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Rhinitis Global Clinical Trials Review, H2, 2014" provides data on the Rhinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rhinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial condu …
- Metastatic Uveal Melanoma：グローバル臨床試験レビュー（2014年上半期）Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Uveal Melanoma Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Uveal Melanoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Uveal Melanoma. It includes an overview of the trial …
- B型肝炎ウイルス（HPV）治療市場：ヨーロッパ主要国の治療薬市場Hepatitis B Virus (HBV) Therapeutics - 5EU Drug Forecast and Market Analysis to 2024 Summary Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people world …
- Kidney Transplantation：グローバル臨床試験レビューH2, 2013Kidney Transplantation Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Kidney Transplantation Global Clinical Trials Review, H2, 2013" provides data on the Kidney Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kidney Transplantation. It includes an overview of the trial numbers and …
- 世界のマザーボード市場予測This report presents worldwide motherboard shipment volume per year for the period 2015 - 2019 and per quarter for the period 1Q 2012 - 2Q 2015. Also included are forecast and recent years' review of worldwide shipment volume and share by region and by CPU connector type, as well as motherboard vs. desktop PC shipment volume ratio on the global basis. This research finds that worldwide commercial …
- ジカンバ除草剤の世界市場予測（～2022年）The dicamba herbicide market is projected to grow at a CAGR of 7.3% to reach USD 521.2 Million by 2022. The market growth is driven by the rising need for food security for the growing population, advancement in farming practices and technologies and heavy crop loss due to weed problems. The market is further driven by factors such as increasing demand for herbicides along with increasing acceptan …
- 爪真菌症(爪白癬)(Onychomycosis (Tinea Unguium))の治療薬パイプライン動向（2015年上半期版）Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015’, provides an overview of the Onychomycosis (Tinea Unguium)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Onychomycosis (Tinea Unguium), complete with comparative analysis at various stages, t …
